JNJ stock: buy or sell?

JNJ stock price: $138.12 -0.22% At close on May 21st, 2019

Updated on:
May 21st, 2019


Johnson & Johnson ended today at $138.12 and stayed constant a bad -0.22%.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide.

Should I buy JNJ stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Johnson & Johnson stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean JNJ will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Johnson & Johnson stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At, we detected 9 ratings published for JNJ stock in the last month.

The general sentiment of these ratings is bullish for JNJ stock, with 5 positive ratings.
Is JNJ a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-5-6Wells Fargo & Con/aOutperform
2019-5-16Credit Suisse Groupn/aOutperform
2019-4-17Raymond JamesOutperformOutperform
2019-4-17Morgan StanleyEqual WeightEqual Weight
2019-4-17Credit Suisse GroupOutperformOutperform
2019-1-23Barclaysn/aEqual Weight
2019-1-2Morgan StanleyEqual WeightEqual Weight
2019-1-14Wells Fargo & CoOutperformOutperform

JNJ stock analysis

Daily outlook

Johnson & Johnson shares stayed constant -0.22% to $138.12 today.

Shares of Johnson & Johnson closed today at $138.12 and stayed stable a bad -0.22%. Since price and SMA200d lines crossed up on January, JNJ climbed $8.65 (6.68%).

JNJ stock chart (daily)

Weekly outlook

Johnson & Johnson shares remained steady -0.35% this week, ending at $138.12. Counting this, it's been 3 red weeks in a row, sliding $-3.89 or a -2.77%.

Since price and SMA40w lines crossed up late January, JNJ climbed $10.73 (8.42%). Far behind is the all-time high Johnson & Johnson marked early December but price is just -6.68% below that top.

JNJ stock chart (weekly)

JNJ stock price history

JNJ stock went public on August 18th, 1980 with a price of $0.011. Since then, JNJ stock surged a 1,381,100.00%, with a yearly average of 36,344.70%. If you had invested $1,000 in JNJ stock in 1980, it would worth $13,811,000.00 today.

1: Adjusted price after possible price splits or reverse-splits.

JNJ stock historical price chart

JNJ stock reached all-time highs on December with a price of $148.01.

JNJ stock price target is $145.90

How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' JNJ stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 9 price predictions for Johnson & Johnson stock:
JNJ stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-5-6Wells Fargo & CoReiterates$152.00$157.003.3%
2019-5-16Credit Suisse GroupRaises Target$152.00$156.002.6%
2019-4-17Raymond JamesRaises Target$145.00$147.001.4%
2019-4-17Morgan StanleyRaises Target$134.00$145.008.2%
2019-4-17Credit Suisse GroupRaises Target$151.00$152.000.7%
2019-1-23BarclaysLowers Target$137.00$135.00-1.5%
2019-1-2Morgan StanleyLowers Target$153.00$130.00-15%
2019-1-2CitigroupLowers Target$148.00$139.00-6.1%
2019-1-14Wells Fargo & CoReiterates$162.00$152.00-6.2%
(in average)$148.20$145.90-2.0%
Moving in a range from $157.00 and $130.00, the price prediction for Johnson & Johnson stock is $145.90.

Financials and fundamental analysis

Earnings date and Earnings per Share

After publishing its last earnings report on Apr/16, Johnson & Johnson remained stable a slightly good 1.17%. Unfortunately, reported EPS is not yet available in our database.
JNJ earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Johnson & Johnson annual sales rose a shining 6.71% to $81,581.00 million USD from $76,450.00 marked in 2017. When comparing 2018 vs 2017, instead, profit margin (that is, the net income divided by revenues) climbed a 17.05% to 18.75%.

Johnson & Johnson fiscal year ends in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Johnson & Johnson TTM sales up to March 2019 were $81,593.00 and income $14,679.00 M USD. When comparing this TTM figures with the last reported annuality, we can review Johnson & Johnson business evolution since December 2018: Annual revenues up to March, compared to lastest yearly report, remained stable a neutral 0.01%. Aligned with this, profit margin (net income/sales) stayed stable at 18.75%.

JNJ annual Sales and Income evolution
2013$71,260 M-$13,830 M19.4%-
2014$74,331 M4.31%$16,323 M22.0%18.03%
2015$70,074 M-5.73%$15,409 M22.0%-5.60%
2016$71,890 M2.59%$16,540 M23.0%7.34%
2017$76,450 M6.34%$1,300 M1.7%-92.14%
2018$81,581 M6.71%$15,297 M18.8%1,076.69%
TTM $81,593 M0.01%$14,679 M18.0%-4.04%

Quarterly financial results

Johnson & Johnson posted $20,021.00 M in sales for 2019-Q1, a -1.83% less compared to previous quarter. Reported quarter income marked $3,749.00 million with a profit margin of 18.73%. Profit margin raised a 3.81% compared to previous quarter when profit margin was 14.92%. When comparing turnover to same quarter last year, Johnson & Johnson sales marked a tight movement and stayed steady a 0.06%.
JNJ quarterly Sales and Income evolution
2017-Q2$18,850 M-$3,830 M20.3%-
2017-Q3$19,650 M4.24%$3,760 M19.1%-1.83%
2017-Q4$20,195 M2.77%$-10,713 M-53.0%-384.92%
2018-Q1$20,009 M-0.92%$4,367 M21.8%-140.76%
2018-Q2$20,830 M4.10%$3,954 M19.0%-9.46%
2018-Q3$20,348 M-2.31%$3,934 M19.3%-0.51%
2018-Q4$20,394 M0.23%$3,042 M14.9%-22.67%
2019-Q1$20,021 M-1.83%$3,749 M18.7%23.24%

Johnson & Johnson ownership

When you are planning to invest in shares of a company, it's worth to review its ownership structure.

Johnson & Johnson shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.07% of all shares.

In case of Johnson & Johnson stock, 69.23% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for JNJ stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Johnson & Johnson:

Market cap$367.4 B$133.8 B$193.7 B$107.4 B$117.6 B
Total shares2,660.0 M1,760.0 M4,920.0 M920.8 M1,340.0 M
Float shares2,650.0 M1,750.0 M2,440.0 M802.0 M1,340.0 M
  - Institutional holdings (%)69.2%76.5%11.0%81.5%84.2%
  - Insider holdings (%)0.1%0.7%0.0%0.1%0.1%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

JNJ summary

Tuesday, May 21st, 2019
Day range$138.08 - $139.57
Previous close$138.42
Session gain-0.22%
Average true range$1.97
50d mov avg$138.33
100d mov avg$135.03
200d mov avg$135.84
Daily patternlt02a
Weekly pattern

Johnson & Johnson performance

To better understand Johnson & Johnson performance you must compare its gains with other related stocks in same sector or industry. In the following table, we compare Johnson & Johnson to , GlaxoSmithKline, Eli Lilly and, Medtronic, Merck, Novartis, Pfizer, and Stryker:
LLYEli Lilly and-5.46%4.42%43.91%

Johnson & Johnson competitors

One check before trading any stock is to have a look a list of its competitors, in this case for Johnson & Johnson. We selected 9 companies as Johnson & Johnson competitors as they are in the same industry or have similar market objectives.

Latest JNJ stock news